Abstract

From Dye to Die – A Systems-based Review for Microfluidic Development & Commercialization

Jim Sirkis, Chief Technology Officer, IDEX Health & Science

The development and successful commercialization of a microfluidic consumable relies upon a complex balance of design, performance, and economic tradeoffs.  Instrument and consumable specifications must be matched to achieve assay goals and designed to address new advances in end user workflows.  Jim Sirkis, Ph.D., is the CTO for IDEX Health & Science. He has many years of experience researching, developing, and manufacturing some of the most successful integrated microfluidic consumables platforms in today’s life sciences market.  Dr. Sirkis will review system-level challenges ranging from fluorescence dye selection to considerations in molding microfluidic components. He will also cover a myriad of other decision-related topics along the development cycle. In the rapidly evolving world of microfluidic consumables, an intelligent and informed approach to design, manufacturability, and product fulfillment will ensure that all aspects of a system’s development are aimed at achieving commercial success.